MEDSTAR FRANKLIN SQUARE MEDICAL CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.1M
- Transactions
- 113
- Companies
- 26
- Average per transaction
- $10,105
Who reported the payments
| Merck | $624,087 |
| Gilead | $385,866 |
| Aesculap Implant Systems, LLC | $23,115 |
| Daiichi Sankyo Inc. | $19,720 |
| Linvatec Corporation | $18,424 |
| Stryker | $13,942 |
| Pfizer | $10,000 |
| Olympus America Inc. | $7,138 |
| Napo Pharmaceuticals Inc | $6,618 |
| TG Therapeutics, Inc. | $5,630 |
| Biotronik Inc. | $5,525 |
| W. L. Gore & Associates, Inc. | $4,136 |
| GE HealthCare | $2,853 |
| Boston Scientific | $2,685 |
| AstraZeneca | $2,500 |
| Genentech USA, Inc. | $2,500 |
| Amgen | $2,500 |
| Accuray Incorporated | $1,650 |
| Johnson & Johnson | $1,501 |
| Edwards Lifesciences | $510 |
| KARL Storz Endoscopy-america | $297 |
| Baxter Healthcare | $237 |
| Zimmer Biomet | $214 |
| American National Red Cross | $111 |
| Abbott | $100 |
| Longeviti Neuro Solutions Inc | $27 |